# Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension

> **NCT03720067** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Universidade Federal do Rio de Janeiro** · enrollment: 80 (estimated)

## Conditions studied

- Cirrhosis
- Portal Hypertension
- Variceal Hemorrhage

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Carvedilol
- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03720067
- **Lead sponsor:** Universidade Federal do Rio de Janeiro
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-25
- **Primary completion:** 2020-12-20
- **Final completion:** 2022-12-20
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720067, "Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03720067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*